Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Operating Margin (2014 - 2026)

Updated

Ocular Therapeutix's Operating Margin was -609.34% in Q2 2026, down 106.77 percentage points from -502.57% a year earlier but up 256.12 percentage points from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Operating Margin (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ocular Therapeutix's Operating Margin was -603.04% through Jun 30, 2026, down 200.44 percentage points year-over-year; for FY2025, it was -519.75%, down 250.18 percentage points from FY2024.

  • Operating Margin shows a five-year change of -158.63 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -269.57% in FY2024 (-128.61 pp), -140.96% in FY2023 (+11.78 pp), -152.74% in FY2022 (+26.56 pp) and -179.30% in FY2021 (+181.82 pp).
  • Quarterly Operating Margin has moved between -865.46% (Q1 2026) and -127.41% (Q3 2023) over five years.
  • Compared with a year earlier, Operating Margin has declined for ten straight quarters, with an average year-over-year change of -216.45 percentage points over the last eight quarters.
  • The best year-over-year quarter for Operating Margin over five years was Q1 2022 (a gain of 140.28 percentage points); the worst was Q1 2025 (a drop of 383.46 percentage points).
  • Per Business Quant data, OCUL's Operating Margin in the three quarters before Q2 2026 was -865.46% (Q1 2026), -526.49% (Q4 2025) and -472.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 28.21%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 37.86%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -3.52%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 32.97%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 20.57%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -133.21%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 37.40%
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn -609.34%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -609.34%
Mar 31, 2026 -865.46%
Dec 31, 2025 -526.49%
Sep 30, 2025 -472.35%
Jun 30, 2025 -502.57%
Mar 31, 2025 -597.47%
Dec 31, 2024 -296.08%
Sep 30, 2024 -298.20%
Jun 30, 2024 -265.13%
Mar 31, 2024 -214.00%
Dec 31, 2023 -135.46%
Sep 30, 2023 -127.41%
Jun 30, 2023 -135.45%
Mar 31, 2023 -168.60%
Dec 31, 2022 -137.56%
Sep 30, 2022 -180.06%
Jun 30, 2022 -162.37%
Mar 31, 2022 -135.23%
Dec 31, 2021 -146.64%
Sep 30, 2021 -160.69%
API Access

Ocular Therapeutix Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEY